[Cerebrolysin in the treatment of brain injuries of moderate severity].
To assess the efficacy of cerebrolysin in patients with cranial/brain injury of moderate severity. The main group included 30 patients treated with cerebrolysin from the first day of disease, the comparison group included 32 patients matched for age, sex and disease severity. Cerebrolysin promoted the early and complete reduction of common symptoms of brain injury as well as autonomic and asthenic disorders, restoration of cognitive functions, normalization of emotional condition, improvement of spontaneous bioelectrical activity. The drug was well-tolerated.